MedMesh.i
Curation
PubMed
Racine
Curation
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Curation (PubMed)

Index « MedMesh.i » - entrée « Administration, Oral »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Administration, Intravenous < Administration, Oral < Administration, Sublingual  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 10.
Ident.Authors (with country if any)Title
000359 (2015) Frédérique Fluchère [France] ; Manon Deveaux ; Borís Burle ; Franck Vidal ; Wery P M. Van Den Wildenberg ; Tatiana Witjas ; Alexandre Eusebio ; Jean-Philippe Azulay ; Thierry HasbroucqDopa therapy and action impulsivity: subthreshold error activation and suppression in Parkinson's disease.
000651 (2013) M. Lagière [France] ; S. Navailles ; L. Mignon ; A. Roumegous ; M-F Chesselet ; P. De DeurwaerdèreThe enhanced oral response to the 5-HT2 agonist Ro 60-0175 in parkinsonian rats involves the entopeduncular nucleus: electrophysiological correlates.
000F19 (????) O. Rascol [France] ; D J Brooks ; E. Melamed ; W. Oertel ; W. Poewe ; F. Stocchi ; E. TolosaRasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial.
001097 (2003) Entacapone/levodopa/carbidopa combination tablet: Stalevo.
001200 (2001) O. Rascol [France] ; I. Arnulf ; H. Peyro-Saint Paul ; C. Brefel-Courbon ; M. Vidailhet ; C. Thalamas ; A M Bonnet ; S. Descombes ; B. Bejjani ; N. Fabre ; J L Montastruc ; Y. AgidIdazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease.
001360 (1999) C. Thalamas [France] ; A. Taylor ; C. Brefel-Courbon ; S. Eagle ; K. Fitzpatrick ; O. RascolLack of pharmacokinetic interaction between ropinirole and theophylline in patients with Parkinson's disease.
001761 (1991) J. Tonet [France] ; C. Guillet ; G. Jondeau ; F. Poulain ; P. Vivet ; R. Frank ; Y. GrosgogeatElectrophysiological effects of intravenous rilmenidine in man.
001794 (1989) P. Rondot [France] ; M. Ziegler ; N. Aymard ; A. TeinturierEffect of controlled-release carbidopa/levodopa on motor performance in advanced Parkinson's disease.
001813 (1989) M. Zreika [France] ; J R Fozard ; M W Dudley ; P. Bey ; I A Mcdonald ; M G PalfreymanMDL 72,974: a potent and selective enzyme-activated irreversible inhibitor of monoamine oxidase type B with potential for use in Parkinson's disease.
001839 (1987) J L Montastruc [France] ; P. Celsis ; A. Agniel ; J F Demonet ; B. Doyon ; M. Puel ; J P Marc-Vergnes ; A. RascolLevodopa-induced regional cerebral blood flow changes in normal volunteers and patients with Parkinson's disease. Lack of correlation with clinical or neuropsychological improvements.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Administration, Oral" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Administration, Oral" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Administration, Oral
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024